Operating Income for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current operating income (TTM) is $665.60M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$665.60M
YoY change
+3.8%
5Y CAGR
+8.1%
Peak year (2022)
$763.50M
Cumulative operating income
$7.02B
Operating Income history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Operating Income history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $617.40M | +3.8% | ||
| 2024 | $594.60M | -16.4% | ||
| 2023 | $710.90M | -6.9% | ||
| 2022 | $763.50M | +0.6% | ||
| 2021 | $758.70M | +81.1% | ||
| 2020 | $419.00M | +41.0% | ||
| 2019 | $297.20M | +16.6% | ||
| 2018 | $254.80M | +10.9% | ||
| 2017 | $229.70M | +6.6% | ||
| 2016 | $215.50M | +71.4% | ||
| 2015 | $125.70M | -30.9% | ||
| 2014 | $181.90M | +16.1% | ||
| 2013 | $156.70M | +14.8% | ||
| 2012 | $136.50M | +17.8% | ||
| 2011 | $115.90M | +9.3% | ||
| 2010 | $106.00M | 0.0% | ||
| 2009 | $106.00M | -14.9% | ||
| 2008 | $124.60M | +10.3% | ||
| 2007 | $113.00M | +6.9% | ||
| 2006 | $105.70M | +44.4% | ||
| 2005 | $73.20M | +14.6% | ||
| 2004 | $63.90M | +17.2% | ||
| 2003 | $54.50M | +104.1% | ||
| 2002 | $26.70M | -35.4% | ||
| 2001 | $41.30M | +15.7% | ||
| 2000 | $35.70M | -46.2% | ||
| 1999 | $66.40M | +2.6% | ||
| 1998 | $64.70M | +4.5% | ||
| 1997 | $61.90M | +16.1% | ||
| 1996 | $53.30M | +10.4% | ||
| 1995 | $48.30M | +2.5% | ||
| 1994 | $47.10M | +14.6% | ||
| 1993 | $41.10M | +3.5% | ||
| 1992 | $39.70M | -3153.8% | ||
| 1991 | -$1.30M | -106.1% | ||
| 1990 | $21.20M | -41.3% | ||
| 1989 | $36.10M | +18.8% | ||
| 1988 | $30.40M | +1.7% | ||
| 1987 | $29.90M | -2.9% | ||
| 1986 | $30.80M | +31.1% | ||
| 1985 | $23.50M | — |
Operating Income values are taken from West Pharmaceutical Services's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of West Pharmaceutical Services (WST) operating income is $617.40M – edged up 3.8% year-over-year.
West Pharmaceutical Services operating income has recorded the values shown across consecutive periods, with a +8.1% compound annual growth rate over 2020–2025 (5 years).
West Pharmaceutical Services operating income declined from $763.50M in 2022 to $617.40M in 2025, a 19.1% drawdown.
$763.50M stands as the all-time-high annual operating income, posted in 2022, against a low of -$1.30M during 1991.
Among 8 Healthcare peers, West Pharmaceutical Services (WST) ranks 9th; the peer median for operating income is $22.84B.
West Pharmaceutical Services Operating Income by Year
West Pharmaceutical Services Operating Income 2025: $617.40M
West Pharmaceutical Services operating income in 2025 was $617.40M, edged up 3.8% from 2024.
West Pharmaceutical Services Operating Income 2024: $594.60M
West Pharmaceutical Services operating income in 2024 was $594.60M, declined 16.4% below 2023.
West Pharmaceutical Services Operating Income 2023: $710.90M
West Pharmaceutical Services operating income in 2023 was $710.90M, declined 6.9% below 2022.
West Pharmaceutical Services Operating Income 2022: $763.50M
West Pharmaceutical Services operating income in 2022 was $763.50M, edged up 0.6% from 2021. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Operating Income 2021: $758.70M
West Pharmaceutical Services operating income in 2021 was $758.70M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Operating Income
Companies in the same sector as West Pharmaceutical Services, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's operating income?
- Latest reported operating income for West Pharmaceutical Services (WST) is $665.60M (period ending March 31, 2026).
How has West Pharmaceutical Services operating income changed year-over-year?
- West Pharmaceutical Services (WST) operating income changed +3.8% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services operating income?
- West Pharmaceutical Services (WST) operating income compound annual growth rate is +8.1% over the most recent 5 years available.
When did West Pharmaceutical Services operating income hit its highest annual value?
- West Pharmaceutical Services operating income reached its highest annual value of $763.50M in 2022.
What was West Pharmaceutical Services operating income in 2024?
- West Pharmaceutical Services (WST) operating income in 2024 was $594.60M.
What was West Pharmaceutical Services operating income in 2025?
- West Pharmaceutical Services (WST) operating income in 2025 was $617.40M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.